Cargando…

In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies

Detalles Bibliográficos
Autores principales:	van Engelen, Nienke, Diets, Illja, Bresters, Dorine, van den Bergen, Janneke C., Vrancken, Alexander F.J.E., Kuiper, Roland P., Jongmans, Marjolijn C.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876415/ https://www.ncbi.nlm.nih.gov/pubmed/34935735 http://dx.doi.org/10.1097/MPH.0000000000002373

Ejemplares similares

Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
por: Flex, Elisabetta, et al.
Publicado: (2014)

TRIM28 variants and Wilms' tumour predisposition
por: Hol, Janna A, et al.
Publicado: (2021)

Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel
por: Byrjalsen, Anna, et al.
Publicado: (2021)

RASopathies: From germline mutations to somatic and multigenic diseases
por: Riller, Quentin, et al.
Publicado: (2021)

RRas2, RhoG and T-cell phagocytosis
por: Alarcón, Balbino, et al.
Publicado: (2012)

Management of rasopathies
por: Yoo, Han-Wook
Publicado: (2013)

Defining RASopathy
por: Rauen, Katherine A.
Publicado: (2022)

RRAS2 shapes the TCR repertoire by setting the threshold for negative selection
por: Martínez-Riaño, Ana, et al.
Publicado: (2019)

Nevus anemicus and RASopathies
por: Bulteel, Charlotte, et al.
Publicado: (2018)

Neurodevelopmental Aspects of RASopathies
por: Kim, Ye Eun, et al.
Publicado: (2019)

RASopathies and cardiac manifestations
por: Hilal, Nazia, et al.
Publicado: (2023)

Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016)

Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities
por: Gilbert-Dussardier, Brigitte, et al.
Publicado: (2016)

The RASopathies: from pathogenetics to therapeutics
por: Hebron, Katie E., et al.
Publicado: (2022)

Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1
por: Witkowski, Leora, et al.
Publicado: (2020)

The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery
por: Kontaridis, Maria I., et al.
Publicado: (2022)

Fine-tuning candidate therapy for RASopathies
Publicado: (2012)

RASopathies: unraveling mechanisms with animal models
por: Jindal, Granton A., et al.
Publicado: (2015)

RASopathies: unraveling mechanisms with animal models
por: Jindal, Granton A., et al.
Publicado: (2015)

RASopathy in Patients With Isolated Sagittal Synostosis
por: Davis, Amani Ali, et al.
Publicado: (2019)

Social behavior in RASopathies and idiopathic autism
por: Foy, Allison M. H., et al.
Publicado: (2022)

Identification of RRAS gene related to nasopharyngeal carcinoma based on pathway and network-based analyses
por: Xiao, Ruowen, et al.
Publicado: (2019)

The Hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?
por: Tan, Mark T. L., et al.
Publicado: (2019)

Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
por: Hortal, Alejandro M., et al.
Publicado: (2022)

Response to the hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-barr virus?
por: Xiao, Ruowen, et al.
Publicado: (2019)

A novel germline PAX5 single exon deletion in a pediatric patient with precursor B-cell leukemia
por: van Engelen, N., et al.
Publicado: (2023)

Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS
por: Perrot, Carole Y., et al.
Publicado: (2018)

Transfection of Sponge Cells and Intracellular Localization of Cancer-Related MYC, RRAS2, and DRG1 Proteins
por: Dominko, Kristina, et al.
Publicado: (2023)

LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies
por: Santoro, Claudia, et al.
Publicado: (2014)

Autism Spectrum Disorder Symptom Profile Across the RASopathies
por: Geoffray, Marie-Maude, et al.
Publicado: (2021)

RASopathies and hemostatic abnormalities: key role of platelet dysfunction
por: Di Candia, Francesca, et al.
Publicado: (2021)

Giant Cell Lesions of the Jaws Involving RASopathy Syndromes
por: Luna, Melissa, et al.
Publicado: (2022)

A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington's Disease
por: Miller, John P., et al.
Publicado: (2012)

The impact of RASopathy-associated mutations on CNS development in mice and humans
por: Kang, Minkyung, et al.
Publicado: (2019)

Endocrine system involvement in patients with RASopathies: A case series
por: Siano, M. A., et al.
Publicado: (2022)

Chronic Idiopathic Axonal Polyneuropathy Is Associated With the Metabolic Syndrome
por: Visser, Nora A., et al.
Publicado: (2013)

METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS
por: Chen, Jie-Xun, et al.
Publicado: (2023)

Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies
por: Leung, Gordon K. C., et al.
Publicado: (2018)

ClinGen’s RASopathy Expert Panel Consensus Methods for Variant Interpretation
por: Gelb, Bruce D., et al.
Publicado: (2018)

TBIO-27. RASOPATHIES AND BRAIN TUMOROGENESIS: ARE SOS1 MUTATIONS ARE CONCERNED?
por: Abdelmoula, Nouha Bouayed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jcuiat9jtc0j3his1vdgbpqrpl